Samuel Harvey, MD PhD. I completed my MD PhD training at the Northwestern University MSTP program. I am currently a PGY-3 AP/CP Pathology Resident at Johns Hopkins. I will be the Molecular Genetic Pathology Fellow at Johns Hopkins during the 2025-2026 academic year.
I completed my MD PhD training in Molecular Genetics and Bioinformatics investigating alternative RNA splicing in cancer metastasis which led to an interest in molecular pathology generally. As a pathology resident, I am currently completing training in both Anatomic and Clinical Pathology with future subspecialty training in Molecular Genetic Pathology. My responsibilities vary depending on the clinical services on which I am rotating in any given month; however, residents are critical members of the team responsible for providing high-quality diagnostic and laboratory services for patients at our health system and internationally through our consult service. .
I have always been inspired by the human desire to understand nature and use that understanding to further the welfare and progress of humankind. Molecular pathology offers so many opportunities to combine the beauty and wonder of molecular biology with practical technologies and treatments to improve human health and well-being.
As a trainee, I am lucky to have the opportunity to learn every day from outstanding mentors. Learning how to solve diverse problems ranging from challenging diagnostic cases to troubleshooting technical assays is engaging and rewarding. At the moment, my biggest challenge at work is deciding where to focus my professional efforts as I approach the end of my training and prepare to enter the job market.
I joined AMP when applying to serve as the junior member on the Clinical Practice Committee at the suggestion of one of my mentors. I was eager to learn more about professional societies in my field and to find a way to contribute to the field-at-large while gaining skills that would be valuable for my future career goals.
I recently attended my first AMP Annual Meeting last November in Salt Lake City, UT. Three valuable aspects of membership I discovered at the meeting were the learning opportunities from courses/lectures, networking opportunities with colleagues in diverse sectors, and committee service/volunteer experiences.
I serve as a junior member on the Clinical Practice Committee and on the Liquid Biopsy Clinical Validation working group. I find it meaningful to be able to craft guidelines and recommendations that will provide a useful framework for clinical laboratories working to implement these technologies.
As a trainee member myself, I would encourage new members to attend the annual meeting. It is probably the most efficient and enjoyable way to learn about everything AMP has to offer and can serve as a springboard for deeper engagement with the association.